Restriction On Generic Drug Switches In DEA eRx Proposal Draws Criticism
Executive Summary
A provision in the Drug Enforcement Administration's proposed rule for electronic prescribing of controlled substances that would prohibit pharmacists from substituting generic drugs for brand name drugs is drawing fire from various stakeholders